Page 146 - Read Online

Page 12 of 12 D’Arcangelo et al. Hepatoma Res 2021;7:4 I http://dx.doi.org/10.20517/2394-5079.2020.109

cirrhosis. J Hepatol2018;69:406-60.
33. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol
2019;70:172-93.
34. Cillo U, Burra P, Mazzaferro V, et al. A multistep, consensus-based approach to organ allocation in liver transplantation: toward a “blended
principle model”. Am J Transplant 2015;15:2552-61.
35. Chang KV, Chen JD, Wu WT, Huang KC, Hsu CT, Han DS. Association between loss of skeletal muscle mass and mortality and tumor
recurrence in hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer 2018;7:90-103.
36. Grąt K, Pacho R, Grąt M, Krawczyk M, Zieniewicz K, Rowiński O. Impact of body composition on the risk of hepatocellular carcinoma
recurrence after liver transplantation. J Clin Med 2019;8:1672.
37. Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-
analysis. PLoS One 2017;12:e0186990.
38. Lucidi C, Lattanzi B, Di Gregorio V, et al. A low muscle mass increases mortality in compensated cirrhotic patients with sepsis. Liver Int
2018;38:851-7.
39. Toniutto P, Zanetto A, Ferrarese A, Burra P. Current challenges and future directions for liver transplantation. Liver Int 2017;37:317-27.
40. Ferrarese A, Germani G, Gambato M, et al. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the
introduction of direct-acting antivirals: a single-center study. World J Gastroenterol 2018;24:4403-11.
41. Ferrarese A, Zanetto A, Gambato M, et al. Liver transplantation for viral hepatitis in 2015. World J Gastroenterol 2016;22:1570-81.
42. Russo FP, Ferrarese A, Zanetto A. Recent advances in understanding and managing liver transplantation. F1000Res 2016;5:2895.